191 related articles for article (PubMed ID: 31499493)
1. Androgen-Secreting Ovarian Tumors.
Macut D; Ilić D; Mitrović Jovanović A; Bjekić-Macut J
Front Horm Res; 2019; 53():100-107. PubMed ID: 31499493
[TBL] [Abstract][Full Text] [Related]
2. Ovarian tumors secreting androgens: an infrequent cause of hyperandrogenism.
Perez Lana M; Demayo S; Monastero A; Nolting M
Minerva Ginecol; 2019 Feb; 71(1):72-77. PubMed ID: 30291701
[TBL] [Abstract][Full Text] [Related]
3. From diagnosis to treatment of androgen-secreting ovarian tumors: a practical approach.
Rojewska P; Meczekalski B; Bala G; Luisi S; Podfigurna A
Gynecol Endocrinol; 2022 Jul; 38(7):537-542. PubMed ID: 35647677
[TBL] [Abstract][Full Text] [Related]
4. Ovarian Leydig cell tumor in a peri-menopausal woman with severe hyperandrogenism and virilization.
Nardo LG; Ray DW; Laing I; Williams C; McVey RJ; Seif MW
Gynecol Endocrinol; 2005 Oct; 21(4):238-41. PubMed ID: 16316848
[TBL] [Abstract][Full Text] [Related]
5. Impact of clinical, hormonal, radiological, and immunohistochemical studies on the diagnosis of postmenopausal hyperandrogenism.
Sarfati J; Bachelot A; Coussieu C; Meduri G; Touraine P;
Eur J Endocrinol; 2011 Nov; 165(5):779-88. PubMed ID: 21896622
[TBL] [Abstract][Full Text] [Related]
6. Direct in-vivo detection of atypical hormonal expression of a Sertoli-Leydig cell tumour following stimulation with human chorionic gonadotrophin.
Cohen I; Shapira M; Cuperman S; Goldberger S; Siegal A; Altaras M; Beyth Y
Clin Endocrinol (Oxf); 1993 Oct; 39(4):491-5. PubMed ID: 8287578
[TBL] [Abstract][Full Text] [Related]
7. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours.
Pascale MM; Pugeat M; Roberts M; Rousset H; Déchaud H; Dutrieux-Berger N; Tourniaire J
Clin Endocrinol (Oxf); 1994 Nov; 41(5):571-6. PubMed ID: 7828344
[TBL] [Abstract][Full Text] [Related]
8. [Sertoli-Leydig cell tumour (arrhenoblastoma) in a patient with polycystic ovary syndrome: clinical, ultrasonographic, hormonal and histopathological evaluation].
Puzigaća S; Prelević G; Svetenović Z; Djuricić S; Kokan Dj; Radivojević U
Srp Arh Celok Lek; 2001; 129 Suppl 1():51-5. PubMed ID: 15637992
[TBL] [Abstract][Full Text] [Related]
9. Postmenopausal androgen-secreting ovarian tumors: challenging differential diagnosis in two cases.
Arteaga E; Martinez A; Jaramilo J; Villaseca P; Cuello M; Valenzuela P; Gejman R; Blumel JE
Climacteric; 2019 Aug; 22(4):324-328. PubMed ID: 30623686
[TBL] [Abstract][Full Text] [Related]
10. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
[TBL] [Abstract][Full Text] [Related]
11. Uterine Tumor Resembling Ovarian Sex Cord Tumor (UTROSCT) Commonly Exhibits Positivity With Sex Cord Markers FOXL2 and SF-1 but Lacks FOXL2 and DICER1 Mutations.
Croce S; de Kock L; Boshari T; Hostein I; Velasco V; Foulkes WD; McCluggage WG
Int J Gynecol Pathol; 2016 Jul; 35(4):301-8. PubMed ID: 26598979
[TBL] [Abstract][Full Text] [Related]
12. Total testosterone and DHEAS levels as predictors of androgen-secreting neoplasms: a populational study.
Waggoner W; Boots LR; Azziz R
Gynecol Endocrinol; 1999 Dec; 13(6):394-400. PubMed ID: 10685333
[TBL] [Abstract][Full Text] [Related]
13. Ovarian sex cord-stromal tumors in patients with probable or confirmed germline DICER1 mutations.
Oost EE; Charles A; Choong CS; Leung YC; Salfinger S; Sonnendecker H; Tan J; Townshend S; Witkowski L; Foulkes WD; Stewart CJ
Int J Gynecol Pathol; 2015 May; 34(3):266-74. PubMed ID: 25844550
[TBL] [Abstract][Full Text] [Related]
14. Leydig cell tumour and mature ovarian teratoma: rare androgen-secreting ovarian tumours in postmenopausal women.
Palha A; Cortez L; Tavares AP; Agapito A
BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27803082
[TBL] [Abstract][Full Text] [Related]
15. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.
Mamoojee Y; Ganguri M; Taylor N; Quinton R
Clin Endocrinol (Oxf); 2018 Jan; 88(1):13-20. PubMed ID: 28980338
[TBL] [Abstract][Full Text] [Related]
16. Ovarian hyperandrogynism as a result of congenital adrenal virilizing disorders: evidence for perinatal masculinization of neuroendocrine function in women.
Barnes RB; Rosenfield RL; Ehrmann DA; Cara JF; Cuttler L; Levitsky LL; Rosenthal IM
J Clin Endocrinol Metab; 1994 Nov; 79(5):1328-33. PubMed ID: 7962325
[TBL] [Abstract][Full Text] [Related]
17. Androgens in Menopausal Women: Not Only Polycystic Ovary Syndrome.
Kostakis EK; Gkioni LN; Macut D; Mastorakos G
Front Horm Res; 2019; 53():135-161. PubMed ID: 31499509
[TBL] [Abstract][Full Text] [Related]
18. Ovarian Leydig Cell Tumor Associated with Recurrent Torsion and Virilization in an Adolescent Patient.
Roth L; Smith AK; Buza N; Coons B; Stitelman D; Vash-Margita A
J Pediatr Adolesc Gynecol; 2024 Apr; 37(2):217-219. PubMed ID: 38110028
[TBL] [Abstract][Full Text] [Related]
19. No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours.
Pelusi C; Forlani G; Zanotti L; Gambineri A; Pasquali R
Clin Endocrinol (Oxf); 2013 Apr; 78(4):533-8. PubMed ID: 22583337
[TBL] [Abstract][Full Text] [Related]
20. [Androgen-secreting tumours of the ovaries].
Jacobsen S; Lauszus FF
Ugeskr Laeger; 2019 Feb; 181(6):. PubMed ID: 30729915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
